Design and Implementation of a National SARS-CoV-2 Monitoring Program in England: REACT-1 Study

Author:

Elliott Paul1,Whitaker Matthew1,Tang David1,Eales Oliver1,Steyn Nicholas1,Bodinier Barbara1,Wang Haowei1,Elliott Joshua1,Atchison Christina1,Ashby Deborah1,Barclay Wendy1,Taylor Graham1,Darzi Ara1,Cooke Graham S.1,Ward Helen1,Donnelly Christl A.1,Riley Steven1,Chadeau-Hyam Marc1

Affiliation:

1. Paul Elliott, Matthew Whitaker, David Tang, Oliver Eales, Barbara Bodinier, Haowei Wang, Christina Atchison, Deborah Ashby, Helen Ward, and Marc Chadeu-Hyam are with the School of Public Health, Imperial College London, UK. Nicholas Steyn and Christl A. Donnelly are with the Department of Statistics, University of Oxford, Oxford, UK. Joshua Elliott is with the Imperial College Healthcare NHS Trust, London. Ara Darzi is with the Institute of Global Health Innovation, Imperial College London. Wendy Barclay...

Abstract

Data System. The REal-time Assessment of Community Transmission-1 (REACT-1) Study was funded by the Department of Health and Social Care in England to provide reliable and timely estimates of prevalence of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection over time, by person and place. Data Collection/Processing. The study team (researchers from Imperial College London and its logistics partner Ipsos) wrote to named individuals aged 5 years and older in random cross-sections of the population of England, using the National Health Service list of patients registered with a general practitioner (near-universal coverage) as a sampling frame. We collected data over 2 to 3 weeks approximately every month across 19 rounds of data collection from May 1, 2020, to March 31, 2022. Data Analysis/Dissemination. We have disseminated the data and study materials widely via the study Web site, preprints, publications in peer-reviewed journals, and the media. We make available data tabulations, suitably anonymized to protect participant confidentiality, on request to the study’s data access committee. Public Health Implications. The study provided inter alia real-time data on SARS-CoV-2 prevalence over time, by area, and by sociodemographic variables; estimates of vaccine effectiveness; and symptom profiles, and detected emergence of new variants based on viral genome sequencing. (Am J Public Health. 2023;113(5):545–554. https://doi.org/10.2105/AJPH.2023.307230 )

Publisher

American Public Health Association

Subject

Public Health, Environmental and Occupational Health

Reference20 articles.

1. Appropriately smoothing prevalence data to inform estimates of growth rate and reproduction number

2. Characterising the persistence of RT-PCR positivity and incidence in a community survey of SARS-CoV-2

3. REACT 1 study materials. Imperial College London. Available at: https://www.imperial.ac.uk/medicine/research-and-impact/groups/react-study/for-researchers/react-1-study-materials. Accessed January 1, 2023.

4. SARS-CoV-2 infection and vaccine effectiveness in England (REACT-1): a series of cross-sectional random community surveys

5. Population estimates for the UK, England and Wales, Scotland and Northern Ireland: mid-2020. Newport, Wales: Office for National Statistics; June 25, 2021.

Cited by 15 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3